Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. KEGG DRUG DrugBank Drug (Description in trials) KEGG GENES KEGG PATHWAY Disease ID
1 Blinatumomab 💬
(Blinatumomab (USAN/INN), Blinatumomab (genetical recombination) (JAN))
[1] Blinatumomab (Blinatumomab)[1] Blinatumomab[4] CD19,
CD3D,
CD3E,
CD3G 💬
[13] B cell receptor signaling pathway, Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬[3] 11, 46, 49 💬